NCT06080607 2024-03-25
PRO
Regina Elena Cancer Institute
Unknown
Clinical Trials
14 trialsNCT06102018 2023-10-26
Diagnostic Biomarkers Exploration of Breast Cancer From Serum and Urine
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Unknown
NCT05969184 2023-08-01
Palbociclib Combine With Anti-HER2 Therapy in Triple Positive ABC
Peking University Cancer Hospital & Institute
Phase 2 Unknown
NCT05600153 2022-10-31
AvBSR
Second Affiliated Hospital, School of Medicine, Zhejiang University
Phase NA Unknown
NCT03662633 2022-10-20
Diagnosis Value of SEMA4C in Breast Cancer
Tongji Hospital
Unknown
NCT05577442 2022-10-19
Trastuzumab, Pyrotinib Combined With Dalpiciclib and Endocrine Therapy for HR +/HER2 + Advanced Breast Cancer
Peking University Cancer Hospital & Institute
Phase 2 Unknown
NCT05244993 2022-07-12
AK105 Plus Anlotinib Hydrochloride Combined With Albumin Paclitaxel as a First-line Therapy in Patients With Advanced Triple-negative Breast Cancer
Liaoning Cancer Hospital & Institute
Phase 2 Unknown
NCT05140655 2021-12-01
Effectiveness and Safety of Fulvestrant in Postmenopausal Women With Advanced Breast Cancer HR+, HER2-
Dr. Reddy's Laboratories SAS
Unknown
NCT03501121 2021-10-06
TARGIT-X
University College, London
Unknown
NCT04927130 2021-06-25
Retrospective Comparative in Vitro Case-controlled Study of the Liquid Biopsy Test System in Women With Breast Cancer
ARNA Genomics US Inc.
Unknown
NCT04456855 2020-07-07
SYSBTC-001
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Unknown
NCT03638414 2018-08-20
ePainQ
The Leeds Teaching Hospitals NHS Trust
Phase NA Unknown
NCT03069885 2018-05-02
iNPWT in Immediate Breast Reconstruction
University of Aarhus
Phase NA Unknown
NCT03011060 2017-01-10
NACVCAC
The First Hospital of Jilin University
Phase 3 Unknown